UPMC Enterprises
Overview
UPMC Enterprises is the innovation, commercialization, and venture capital arm of UPMC, a major health care provider and insurer. The firm invests in and supports companies from early to growth stages, focusing on two main areas: Translational Sciences, which includes cutting-edge diagnostics and therapeutics, and Digital Solutions, which involves building innovative products and technologies.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Cerevance | May 2026 | Series C | Co-investor |
| RAAPID INC | Mar 2026 | Series A Extension | Lead |
| BrainCheck | Feb 2026 | Series A | Co-investor |
| RxAnte | Jan 2026 | Private Equity | Co-investor |
| Penguin Ai | Sep 2025 | Series A | Co-investor |
Key People
Eamonn Fitzgerald
Managing Director UPMC Ireland
Mary Motts
Managing Director
Christopher Howe
Human Resource Busines Partner
Isaiah Barnett
Associate I II Service Partner
Abdelhamid Saoudi
Principal Medical Physicist
Alyssa Zampogna
Research Principal
Amy Ionadi
Research Principal Sr
Bart Billy
Senior Research Principal
Brandon Goodling
Principal Trainer
Dan Snyder
Chief Principal Architect
Danielle Werth
Epic OpTime And Anesthesia Principal Trainer
Darlene Melchitzky
Research Principal
Dominique Arion
Research Principal Senior
Elizabeth Fyne
Research Principal, Sr.
Ioana Neagoe
Research Principal
Jamie Durbin
Research Principal Sr
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
